METAGENOMI INC. - COMMON STOCK

Metagenomi to Present at Upcoming Scientific Meetings

02 5月 2025 07:00:00 条件 Nasdaq GlobeNewswire

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

17 3月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

13 3月 2025 06:19:32 条件 Nasdaq GlobeNewswire

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

11 2月 2025 08:55:00 条件 Nasdaq GlobeNewswire

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

16 1月 2025 08:55:00 条件 Nasdaq GlobeNewswire

Metagenomi Announces New Appointment to its Board of Directors

15 1月 2025 08:55:00 条件 Nasdaq GlobeNewswire

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08 1月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

11 12月 2024 18:30:00 条件 Nasdaq GlobeNewswire

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

09 12月 2024 21:16:48 条件 Nasdaq GlobeNewswire

Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

13 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

05 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT

24 10月 2024 08:04:50 条件 Nasdaq GlobeNewswire

Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies

14 10月 2024 20:58:21 条件 Nasdaq GlobeNewswire

Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference

19 9月 2024 19:15:11 条件 Nasdaq GlobeNewswire

Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months

03 9月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference

29 8月 2024 19:32:08 条件 Nasdaq GlobeNewswire

Metagenomi to Participate in Upcoming Investor Conferences

28 8月 2024 18:10:18 条件 Nasdaq GlobeNewswire

Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results

14 8月 2024 08:05:00 条件 Nasdaq GlobeNewswire

Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference

29 5月 2024 16:00:00 条件 Nasdaq GlobeNewswire

Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results

14 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire